0001213900-20-031869.txt : 20201016
0001213900-20-031869.hdr.sgml : 20201016
20201016203727
ACCESSION NUMBER: 0001213900-20-031869
CONFORMED SUBMISSION TYPE: 4/A
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20201013
FILED AS OF DATE: 20201016
DATE AS OF CHANGE: 20201016
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Brady Brian Michael
CENTRAL INDEX KEY: 0001817386
FILING VALUES:
FORM TYPE: 4/A
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39336
FILM NUMBER: 201245028
MAIL ADDRESS:
STREET 1: 11161 ANDERSON STREET
STREET 2: SUITE 105-10014
CITY: LOMA LINDA
STATE: CA
ZIP: 92354
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ADiTx Therapeutics, Inc.
CENTRAL INDEX KEY: 0001726711
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 823204328
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 11161 ANDERSON STREET
STREET 2: SUITE 105-10014
CITY: LOMA LINDA
STATE: CA
ZIP: 92354
BUSINESS PHONE: 909-488-0844
MAIL ADDRESS:
STREET 1: 11161 ANDERSON STREET
STREET 2: SUITE 105-10014
CITY: LOMA LINDA
STATE: CA
ZIP: 92354
4/A
1
ownership.xml
X0306
4/A
2020-10-13
2020-10-15
0
0001726711
ADiTx Therapeutics, Inc.
ADTX
0001817386
Brady Brian Michael
C/O ADITX THERAPEUTICS, INC.
11161 ANDERSON STREET, SUITE 105-10014
LOMA LINDA
CA
92354
1
0
0
0
Stock Option (Right to Buy)
1.94
2020-10-13
4
A
0
10000
0
A
2030-10-13
Common Stock
10000
10000
D
25% of the stock options vest immediately, and the remaining 75% of the stock options will vest in three equal quarterly installments on the last day of each subsequent fiscal quarter, beginning December 31, 2020.
This Amendment is being filed to correct a clerical error. Column 4 in Table II has been changed to reflect the transaction as an acquisition rather than a disposition.
/s/ Brian M. Brady
2020-10-16